Siegfried Holding AG (FRA:SQG0)

Market Cap	3.87B -5.1%
Revenue (ttm)	1.43B +2.6%
Net Income	181.16M +5.4%
EPS	4.12 +4.1%
Shares Out	n/a
PE Ratio	21.36
Forward PE	20.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	87.40
Previous Close	88.10
Day's Range	84.90 - 87.40
52-Week Range	74.00 - 108.06
Beta	n/a
RSI	52.70
Earnings Date	Aug 21, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Pharmaceutical Preparations
• Founded: 1873
• Employees: 3,891
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SQG0

Financial Performance

In 2025, Siegfried Holding AG's revenue was 1.33 billion, an increase of 2.57% compared to the previous year's 1.29 billion. Earnings were 168.66 million, an increase of 5.37%.

Financial numbers in CHF